Vaginal mucosal immune milieu

The vaginal mucosal immune milieu represents the integrated biological system of the female lower reproductive tract, encompassing the stratified squamous epithelial barrier, resident microbiota, and diverse immune mediators such as cytokines, chemokines, and antimicrobial peptides (Anahtar et al., 2015, Immunity). This environment serves as the primary defense against sexually transmitted infections (STIs), including HIV-1, by maintaining an acidic pH through Lactobacillus-mediated lactic acid production and secreting protective factors like secretory leukocyte protease inhibitor (SLPI) (Wira et al., 2011, American Journal of Reproductive Immunology). The milieu's composition is highly dynamic and is influenced by hormonal fluctuations during the menstrual cycle, sexual activity, and hygiene practices (Ravel et al., 2011, PNAS). Dysregulation of this system, often characterized by a shift from Lactobacillus dominance to a diverse array of anaerobic bacteria (bacterial vaginosis), results in elevated pro-inflammatory cytokines and increased recruitment of HIV-susceptible target cells (Passmore et al., 2016, Current Opinion in HIV and AIDS). Consequently, the vaginal mucosal immune milieu is a critical focus for the development of microbicides, vaccines, and probiotic therapies aimed at enhancing mucosal protection and preventing infection (Nunn and Forney, 2016, Antiviral Research).

Other names

Vaginal immune environmentVaginal mucosal immunityCervicovaginal immune milieuVaginal microenvironmentFemale reproductive tract immune system

Modulation of the vaginal microbiota to maintain Lactobacillus dominance, regulation of pro-inflammatory cytokine production (e.g., IL-1, IL-8), and reinforcement of the physical and chemical epithelial barrier to prevent pathogen translocation.